We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
LaxenaireMC. Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry.Ann Fr Anesth Reanim1993; 12: 91–96.Google Scholar
LaxenaireMC. Substances responsible for peranesthetic anaphylactic shock. A third French multicenter study (1992–94).Ann Fr Anesth Reanim1996; 15: 1211–1218.Google Scholar
LaxenaireMC, MertesPM. Anaphylaxis during anaesthesia. Results of a two-year survey in France.Br J Anaesth2001; 87: 549–558.Google Scholar
LarocheD, BricardH, LaxenaireMC. Allergo-anesthesia consultation: not enough patients are tested after an anaphylactoid anesthetic incident.Ann Fr Anesth Reanim1998; 17: 89–90.Google Scholar
BrysonHM, FauldsD. Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice.Drugs1997; 53: 848–866.Google Scholar